Key Quantitative Figures - Standalone (₹ in Lakhs)

Quarter Ended June 30, 2026 (Unaudited):

  • Total Revenue: 60.50
  • Profit/(Loss) Before Tax: (1.64)
  • Net Profit/(Loss) for the Period: (1.51)
  • Total Comprehensive Income: (1.55)
  • Basic & Diluted EPS (₹): (0.01)

Comparative Figures:

  • Quarter Ended June 30, 2025: Net Profit of 4.18
  • Year Ended March 31, 2026: Net Profit of 40.73

Capital Structure:

  • Paid-up Equity Share Capital (Face Value ₹10): 2,501.62

Key Quantitative Figures - Consolidated (₹ in Lakhs)

Quarter Ended June 30, 2026 (Unaudited):

  • Total Revenue: 60.50
  • Profit Before Tax & Share of Associate: (1.64)
  • Share in Profit of Associate: 456.46
  • Net Profit for the Period: 454.95
  • Total Comprehensive Income: 454.10
  • Basic & Diluted EPS (₹): 1.82

Comparative Figures:

  • Quarter Ended June 30, 2025: Net Profit of 278.34
  • Year Ended March 31, 2026: Net Profit of 279.26

Capital Structure:

  • Paid-up Equity Share Capital (Face Value ₹10): 2,501.62
  • Other Equity (as of Mar 31, 2026): 8,125.59

Parties Involved

Associates: Titan Biotech Limited, Peptech Biosciences Limited

Statutory Auditors: Goyal Nagpal & Co. (Firm Regn. No. 018289C)

Reviewing Partner: CA Virender Nagpal (M.No. 416004)

Management Change

Appointment of CFO: Mr. Ranjeet Kumar was appointed as Chief Financial Officer (KMP) effective August 13, 2026.

Profile: Mr. Kumar holds a B.Com (Hons) from Magadh University and has completed CA Intermediate. He has over 15 years of experience in accounts, taxation, and financial management.

Dates of Action

  • Board Meeting: August 13, 2026 (5:00 PM to 5:30 PM)
  • Financial Results Period: Quarter ended June 30, 2026
  • CFO Appointment Effective: August 13, 2026
  • Auditor's Review Date: August 13, 2026

Financial Impact

The financial impact is fully quantified in the disclosure for both standalone and consolidated operations. The consolidated results are significantly influenced by the share of profit from associates.

Additional Information

The standalone and consolidated financial results have been reviewed by the Audit Committee and approved by the Board. The Statutory Auditors, Goyal Nagpal & Co., have issued an unmodified review conclusion on both sets of results. The information is available on the company's website (www.titansecuritieslimited.com) and the BSE website (www.bseindia.com).